Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE Study
Studies have shown that the protection afforded by COVID-19 vaccines against hospitalization and death decreases slowly over time due to the emergence of new variants and waning immunity. Accordingly, booster doses remain critical to minimizing the health impacts of the pandemic. This study examined...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-01-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/11/2/291 |
| _version_ | 1797617900264095744 |
|---|---|
| author | Camille Léger Frédérique Deslauriers Vincent Gosselin Boucher Meghane Phillips Simon L. Bacon Kim L. Lavoie |
| author_facet | Camille Léger Frédérique Deslauriers Vincent Gosselin Boucher Meghane Phillips Simon L. Bacon Kim L. Lavoie |
| author_sort | Camille Léger |
| collection | DOAJ |
| description | Studies have shown that the protection afforded by COVID-19 vaccines against hospitalization and death decreases slowly over time due to the emergence of new variants and waning immunity. Accordingly, booster doses remain critical to minimizing the health impacts of the pandemic. This study examined the prevalence rate, sociodemographic determinants, and motivators of getting a COVID-19 booster vaccine within the Canadian population. We recruited a representative sample of 3001 Canadians aged 18+ years as part of the iCARE study using an online polling form between 20 January and 2 February 2022. Participants self-reported their booster status and were dichotomized into two groups: those who did vs. did not receive at least one booster dose. A total of 67% of participants received a booster dose. Chi-square analyses revealed that older age (<i>p</i> < 0.001) and having a chronic disease diagnosis (<i>p</i> < 0.001) were associated with being more likely to get a booster. Boosted individuals reported motivators tied to efficacy and altruism, whereas non-boosted individuals reported motivators tied to efficacy and safety. Results suggest that messaging will require careful tailoring to address the identified behavioral motivators among non-boosted individuals who emphasize safety and efficacy of additional vaccine doses. |
| first_indexed | 2024-03-11T08:02:33Z |
| format | Article |
| id | doaj.art-2211708e664540128854d6cedea6bf1f |
| institution | Directory Open Access Journal |
| issn | 2076-393X |
| language | English |
| last_indexed | 2024-03-11T08:02:33Z |
| publishDate | 2023-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Vaccines |
| spelling | doaj.art-2211708e664540128854d6cedea6bf1f2023-11-16T23:42:22ZengMDPI AGVaccines2076-393X2023-01-0111229110.3390/vaccines11020291Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE StudyCamille Léger0Frédérique Deslauriers1Vincent Gosselin Boucher2Meghane Phillips3Simon L. Bacon4Kim L. Lavoie5Department of Psychology, University of Québec at Montreal (UQAM), Montréal, QC C3H 3P8, CanadaDepartment of Psychology, University of Québec at Montreal (UQAM), Montréal, QC C3H 3P8, CanadaSchool of Kinesiology, University of British Columbia, Vancouver, BC V6T 1Z1, CanadaMontreal Behavioural Medicine Centre, Centre Intégré Universitaire de Santé et de Services Sociaux du Nord de l’Ile de Montréal (CIUSSS-NIM), Montréal, QC H4J 1C5, CanadaMontreal Behavioural Medicine Centre, Centre Intégré Universitaire de Santé et de Services Sociaux du Nord de l’Ile de Montréal (CIUSSS-NIM), Montréal, QC H4J 1C5, CanadaDepartment of Psychology, University of Québec at Montreal (UQAM), Montréal, QC C3H 3P8, CanadaStudies have shown that the protection afforded by COVID-19 vaccines against hospitalization and death decreases slowly over time due to the emergence of new variants and waning immunity. Accordingly, booster doses remain critical to minimizing the health impacts of the pandemic. This study examined the prevalence rate, sociodemographic determinants, and motivators of getting a COVID-19 booster vaccine within the Canadian population. We recruited a representative sample of 3001 Canadians aged 18+ years as part of the iCARE study using an online polling form between 20 January and 2 February 2022. Participants self-reported their booster status and were dichotomized into two groups: those who did vs. did not receive at least one booster dose. A total of 67% of participants received a booster dose. Chi-square analyses revealed that older age (<i>p</i> < 0.001) and having a chronic disease diagnosis (<i>p</i> < 0.001) were associated with being more likely to get a booster. Boosted individuals reported motivators tied to efficacy and altruism, whereas non-boosted individuals reported motivators tied to efficacy and safety. Results suggest that messaging will require careful tailoring to address the identified behavioral motivators among non-boosted individuals who emphasize safety and efficacy of additional vaccine doses.https://www.mdpi.com/2076-393X/11/2/291vaccineboostermotivatorsCOVID-19cross-sectional survey |
| spellingShingle | Camille Léger Frédérique Deslauriers Vincent Gosselin Boucher Meghane Phillips Simon L. Bacon Kim L. Lavoie Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE Study Vaccines vaccine booster motivators COVID-19 cross-sectional survey |
| title | Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE Study |
| title_full | Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE Study |
| title_fullStr | Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE Study |
| title_full_unstemmed | Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE Study |
| title_short | Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE Study |
| title_sort | prevalence and motivators of getting a covid 19 booster vaccine in canada results from the icare study |
| topic | vaccine booster motivators COVID-19 cross-sectional survey |
| url | https://www.mdpi.com/2076-393X/11/2/291 |
| work_keys_str_mv | AT camilleleger prevalenceandmotivatorsofgettingacovid19boostervaccineincanadaresultsfromtheicarestudy AT frederiquedeslauriers prevalenceandmotivatorsofgettingacovid19boostervaccineincanadaresultsfromtheicarestudy AT vincentgosselinboucher prevalenceandmotivatorsofgettingacovid19boostervaccineincanadaresultsfromtheicarestudy AT meghanephillips prevalenceandmotivatorsofgettingacovid19boostervaccineincanadaresultsfromtheicarestudy AT simonlbacon prevalenceandmotivatorsofgettingacovid19boostervaccineincanadaresultsfromtheicarestudy AT kimllavoie prevalenceandmotivatorsofgettingacovid19boostervaccineincanadaresultsfromtheicarestudy |